Blood biomarkers at disease onset may help predict relapse-associated worsening and progression independent of relapse activity (PIRA) in multiple sclerosis (MS), an observational study suggested. Patients with high NfL at disease onset may benefit from high-efficacy treatments.
Blood Markers Help Predict MS Disease Pr... - My MSAA Community
Blood Markers Help Predict MS Disease Progression
Written by
BettysMom
To view profiles and participate in discussions please or .
3 Replies
•
This would have been brilliant when I first got diagnosed 9 years ago! Spent 6 years on copaxone, to then be put on ocrevus, because my MS is apparently aggressive. Since being on ocrevus, there's been no sign of new lesions. I'm still just a RRMSer 🙏
My Neurologist does this for me.
The science could be really useful. I just hope insurers would not use those results to try to get out of paying for high-effucacy treatments for those whose biomarkers markers did not predict RAW and PIRA.
Not what you're looking for?
You may also like...
Investigational MS Med Nearly Eliminates Disease Activity on MRI
NASHVILLE, TENNESSEE — A second-generation anti-CD40L monoclonal antibody suppresses multiple...
Blood Test for MS Activity Gets FDA Breakthrough Designation
The US Food and Drug Administration (FDA) has granted breakthrough device designation to the...
Relapse
I just had my first relapse since being diagnosed 7 years ago. I had been taking Tecifedera, which...
NeuroCovid and psych issues
Hi everybody,
i came across this article in a social work journal and thought i would share it...